StockIQpro
NASDAQ:NMTC

NEUROONE MEDICAL TECHNOLOGIES Corp

Track all markets on TradingView
Track all markets on TradingView

NEUROONE MEDICAL TECHNOLOGIES Corp's revenue grew 163.5% in fiscal 2025 to $9.1M while operating margin rose to −46.5%, its highest in 5 years. Free cash flow was −$2.9M, −32.1% of revenue, and the diluted share count rose 50.0%.Summary generated from NEUROONE MEDICAL TECHNOLOGIES Corp's SEC filings. Latest annual report filed Dec 17, 2025.

Key statistics

Fiscal 2025 from SEC filings. Methodology
Revenue (FY25)$9.1M
Revenue growth+163.5%
Revenue, 5-yr CAGRn/a
Gross margin56.5%
Operating margin−46.5%
Net margin−39.6%
ROICn/a
Return on equity−91.3%
Debt / equityn/a
Free cash flow−$2.9M
FCF margin−32.1%
Share count change+50.0%

Financials

Fiscal years, $M
Item20212022202320242025
Revenue00239
Operating income−10−10−12−12−4
Net income−10−10−12−12−4
Free cash flow−9−8−13−11−3

Recent filings

From SEC EDGAR

Peers

Surgical & medical instruments & apparatus